XDH and chronic kidney disease: Subgroup analyses indicated greater benefit in elderly patients, females, and those with DM or CKD, highlighting the potential of XO inhibitors to mitigate oxidative stress-related CVD in patients with hyperuricemia and comorbid DM [191].